NSE Conference Vaccination Policy
All NSE coordinators and guests attending the March 2022 conference and events beyond that date are required to be fully vaccinated and will be required to provide proof of their vaccination. NSE will provide additional information on a secure, digital platform for this process closer to the conference date. NSE strives to protect the health and safety of our community to the fullest extent possible and enable our conference participants to engage in-person and more fully in various aspects of organization events. NSE will continue to make safety the primary consideration in its decision-making, and will rely on the most up-to-date scientific information available to make informed decisions about its operations. Proof of a negative COVID-19 test is NOT sufficient for access to the event.
NSE Conference Mask Policy
Everyone attending the NSE Conference, regardless of vaccination status, must wear a mask in all indoor public settings. It is strongly recommended that you wear a mask while at outdoor events with people outside your household.
Vaccination Record Card
Bring your COVID-19 vaccination record card. Proof of vaccination may be required for admission to museums, attractions, restaurants, or other venues.
Every attendee should plan to enroll and add their record of COVID-19 vaccination to an online application at least 48 hours before their arrival at the March 2022 NSE Conference. For the purposes of this event, a person is considered vaccinated:
• 2 weeks after their second dose in a 2-dose series, such as Pfizer and Moderna vaccines, or
• 2 weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine
This guidance applies to COVID-19 vaccines authorized for emergency use by the U.S. Food and Drug Administration (i.e., Pfizer-BioNTech, Moderna, and Johnson and Johnson (J&J)/Janssen COVID-19 vaccines); COVID-19 vaccines authorized for emergency use by the Government of Canada (i.e., AstraZeneca/Oxford, Pfizer-BioNTech, Moderna, and Johnson and Johnson (J&J)/Janssen COVID-19 vaccines); and COVID-19 vaccines authorized for emergency use by the World Health Organization (i.e., AstraZeneca/Oxford, Covishield, Sinopharm, and Sinovac).
Additional information will be shared as it is available.
Local COVID-19 Information: